Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.

Saved in:
Bibliographic Details
Title: Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
Authors: Shah BD; Moffitt Cancer Center, Tampa, FL, USA. bijal.shah@moffitt.org., Cassaday RD; University of Washington & Fred Hutchinson Cancer Center, Seattle, WA, USA., Park JH; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Houot R; CHU Rennes, Univ Rennes, Inserm & EFS, Rennes, France., Logan AC; UCSF Medical Center, San Francisco, CA, USA., Boissel N; Hôpital Saint-Louis, Paris, France., Leguay T; Service d'hématologie clinique et thérapie cellulaire Hopital du Haut-Lévêque CHU de Bordeaux, Bordeaux, France., Bishop MR; The University of Chicago Medicine, Chicago, IL, USA., Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., O'Dwyer KM; University of Rochester Medical Center, Rochester, NY, USA., Tzachanis D; University of California San Diego, San Diego, CA, USA., Arellano ML; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Lin Y; Mayo Clinic, Rochester, MN, USA., Baer MR; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Schiller GJ; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Subklewe M; Ludwig-Maximilians-Universität München, München, Germany., Abedi M; University of California Davis Comprehensive Cancer Center Sacramento, Davis, CA, USA., Minnema MC; UMC Utrecht Cancer Center, MS Hematologie, University Medical Center Utrecht, on behalf of HOVON/LLPC, Utrecht, Netherlands., Wierda WG; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DeAngelo DJ; Dana-Farber Cancer Institute, Boston, MA, USA., Stiff P; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA., Jeyakumar D; University of California Irvine Medical Center, Orange, CA, USA., Mao D; Kite, a Gilead Company, Santa Monica, CA, USA., Adhikary S; Kite, a Gilead Company, Santa Monica, CA, USA., Zhou L; Kite, a Gilead Company, Santa Monica, CA, USA., Hadjivassileva T; Kite, a Gilead Company, Santa Monica, CA, USA., Damico Khalid R; Kite, a Gilead Company, Santa Monica, CA, USA., Ghobadi A; Washington University School of Medicine, St Louis, MO, USA., Oluwole OO; Vanderbilt University Cancer Center, Nashville, TN, USA.
Source: Leukemia [Leukemia] 2025 May; Vol. 39 (5), pp. 1058-1068. Date of Electronic Publication: 2025 Mar 19.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-025-02532-7